| The contribution of the IL-17/ IL-23 axis to the pathogenesis of inflammatory bowel disease. DDL Cătană CS, Berindan-Neagoe I, Cozma V, Magdaş C, Tăbăran F World Journal of Gastroenterology, 2015 | 212* | 2015 |
| Natural products with anti-aging potential: Affected targets and molecular mechanisms CS Cătană, AG Atanasov, I Berindan-Neagoe Biotechnology advances 36 (6), 1649-1656, 2018 | 89 | 2018 |
| NCRNA combined therapy as future treatment option for cancer. BNI Braicu C, Cătană CS, Călin GA Current Pharmacological Design 20 (42), 6565-6574, 2014 | 62* | 2014 |
| SIRT1 in the development and treatment of hepatocellular carcinoma M Farcas, AA Gavrea, D Gulei, C Ionescu, A Irimie, CS Catana, ... Frontiers in nutrition 6, 148, 2019 | 46 | 2019 |
| Non-coding RNAs: prevention, diagnosis, and treatment in myocardial ischemia–reperfusion injury MC Marinescu, AL Lazar, MM Marta, A Cozma, CS Catana International Journal of Molecular Sciences 23 (5), 2728, 2022 | 36 | 2022 |
| Inflamma-miRs in aging and breast cancer: are they reliable players? CS Cătană, GA Calin, I Berindan-Neagoe Frontiers in medicine 2, 85, 2015 | 35 | 2015 |
| Non-coding RNAs, the Trojan horse in two-way communication between tumor and stroma in colorectal and hepatocellular carcinoma CS Cătană, M Pichler, G Giannelli, RM Mader, I Berindan-Neagoe Oncotarget 8 (17), 29519, 2017 | 30 | 2017 |
| Comparison of two models of inflammatory bowel disease in rats CS Catana, C Magdas, FA Tabaran, EC Craciun, G Deak, VA Magdas, ... Adv. Clin. Exp. Med 27, 599-607, 2018 | 26 | 2018 |
| Evaluation of chitotriosidase and neopterin as biomarkers of microvascular complications in patients with type 1 diabetes mellitus A Cutaș, C Drugan, G Roman, A Rusu, CS Cătană, A Achimaș-Cadariu, ... Diagnostics 11 (2), 263, 2021 | 13 | 2021 |
| The significance of PDGF expression in serum of colorectal carcinoma patients-correlation with Dukes classification. Can PDFG become a potential biomarker? IC Braicu C, Tudoran O, Balacescu L, Cătană CS, Neagoe E, Berindan-Neagoe I Chirurgia 108, 849-854, 2013 | 13* | 2013 |
| Implications of long non-coding RNAs in age-altered proteostasis CS Catana, CA Crișan, D Opre, I Berindan-Neagoe Aging and disease 11 (3), 692, 2020 | 9 | 2020 |
| Evaluation of Chitotriosidase as a marker of inflammatory status in critical limb ischemia RA Ciocan, C Drugan, CD Gherman, CS Cătană, A Ciocan, TC Drugan, ... Annals of Clinical & Laboratory Science 47 (6), 713-719, 2017 | 9 | 2017 |
| Evaluation of neopterin as a biomarker for the monitoring of Gaucher disease patients C Drugan, TC Drugan, N Miron, P Grigorescu-Sido, I Naşcu, C Cătană Hematology 21 (6), 379-386, 2016 | 9 | 2016 |
| Is interleukin-17 a proatherogenic biomarker CS Cãtanã, V Cristea, N Miron, IB Neagoe Roum. Arch. Microbiol. Immunol 70 (3), 124-128, 2011 | 8 | 2011 |
| Diagnostic and prognostic value of microRNAs for Alzheimer’s disease: a comprehensive meta-analysis CS Cătană, CA Crişan, D Opre, I Berindan-Neagoe Medicine and Pharmacy Reports 93 (1), 53, 2020 | 7 | 2020 |
| Aging and immunity CS Cătană, I Berindan-Neagoe Age related changes in immunological, biochemical and genetic markers …, 2012 | 5 | 2012 |
| Exploratory evaluation of neopterin and chitotriosidase as potential circulating biomarkers for colorectal cancer A Ciocan, RA Ciocan, N Al Hajjar, AM Benea, SL Pandrea, CS Cătană, ... Biomedicines 11 (3), 894, 2023 | 4 | 2023 |
| Waist to height ratio in nonalcoholic fatty liver disease–Systematic review and meta-analysis A Ismaiel, B El Hosiny, M Ismaiel, DC Leucuta, SL Popa, CS Catana, ... Clinics and Research in Hepatology and Gastroenterology 47 (7), 102160, 2023 | 3 | 2023 |
| Chitotriosidase and Neopterin as Potential Biomarkers for the Evaluation of Complicated Cholecystitis—A Pilot Study VI Nechita, NA Hajjar, C Drugan, CS Cătană, E Moiş, MA Nechita, F Graur Journal of Clinical Medicine 12 (4), 1641, 2023 | 3 | 2023 |
| Evaluation of Circulating Chitotriosidase Activity in Children with Obesity I Țaranu, M Iancu, C Lazea, C Alkhzouz, N Răcătăianu, CS Cătană, ... Journal of Clinical Medicine 11 (13), 3634, 2022 | 3 | 2022 |
ioana berindan neagoeUniversity of Medicine and Pharmacy Iuliu Hatieganu Cluj Napoca在 umfcluj.ro 的电子邮件经过验证
